1-4 of 4
therapy naive
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials

Jennifer A. Woyach
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 476–481.
https://doi.org/10.1182/hematology.2019001321
Published: 2019
Journal Articles

Management of newly diagnosed immune thrombocytopenia: can we change outcomes?

Cindy E. Neunert
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 400–405.
https://doi.org/10.1182/asheducation-2017.1.400
Published: 2017
Journal Articles

Nontransplant therapy for bone marrow failure

Danielle M. Townsley, Thomas Winkler
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 83–89.
https://doi.org/10.1182/asheducation-2016.1.83
Published: 2016
Journal Articles

Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Approach to Patients with Treatment-Naive or Refractory Chronic-Phase Disease

Catherine C. Smith, Neil P. Shah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 121–127.
https://doi.org/10.1182/asheducation-2011.1.121
Published: 2011